90 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
the Restricted Period, then the Executive will have the duty and responsibility to promptly notify the Company of such relationship and cooperate in any
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts
8-K
EX-10.2
bjgu3zyyocpd1cx924k
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-10.1
ru6mr
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-10.1
bua egzmtn
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
424B3
gpkln4kbu6 05g4
19 Oct 22
Prospectus supplement
6:10am
8-K
EX-10.1
60ultntlc1375c4vo
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
15smloqo5qb q60c9um
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
8-K
EX-10.1
le10lf
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
u9do b8c4igwc4g
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
5yr ovsk8pf4z47
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
kwoopn25
25 Apr 22
Prospectus supplement
5:02pm